EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieOpen Access · CC BY 4.0

LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes

Jingzhong Ding, Anh Tram Nguyen, Kurt Lohman, Michael T Hensley, Daniel Parker, Li Hou, Jackson Taylor, Deepak Voora, Janet K Sawyer, Elena Boudyguina, Michael P Bancks, Alain Bertoni und 19 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci173278 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Jingzhong Ding und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Prediabetic State, Diabetes Mellitus, Type 2, Liver X Receptors, Cholesterol. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUNDPreclinical studies suggest that cholesterol accumulation leads to insulin resistance. We previously reported that alterations in a monocyte cholesterol metabolism transcriptional network (CMTN) - suggestive of cellular cholesterol accumulation - were cross-sectionally associated with obesity and type 2 diabetes (T2D). Here, we sought to determine whether the CMTN alterations independently predict incident prediabetes/T2D risk, and correlate with cellular cholesterol accumulation.METHODSMonocyte mRNA expression of 11 CMTN genes was quantified among 934 Multi-Ethnic Study of Atherosclerosis (MESA) participants free of prediabetes/T2D; cellular cholesterol was measured in a subset of 24 monocyte samples.RESULTSDuring a median 6-year follow-up, lower expression of 3 highly correlated LXR target genes - ABCG1 and ABCA1 (cholesterol efflux) and MYLIP (cholesterol uptake suppression) - and not other CMTN genes, was significantly associated with higher risk of incident prediabetes/T2D. Lower expression of the LXR target genes correlated with higher cellular cholesterol levels (e.g., 47% of variance in cellular total cholesterol explained by ABCG1 expression). Further, adding the LXR target genes to overweight/obesity and other known predictors significantly improved prediction of incident prediabetes/T2D.CONCLUSIONThese data suggest that the aberrant LXR/ABCG1-ABCA1-MYLIP pathway (LAAMP) is a major T2D risk factor and support a potential role for aberrant LAAMP and cellular cholesterol accumulation in diabetogenesis.FUNDINGThe MESA Epigenomics and Transcriptomics Studies were funded by NIH grants 1R01HL101250, 1RF1AG054474, R01HL126477, R01DK101921, and R01HL135009. This work was supported by funding from NIDDK R01DK103531 and NHLBI R01HL119962.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prediabetic StateDiabetes Mellitus, Type 2Liver X ReceptorsCholesterolSignal TransductionHumansMaleFemaleMiddle AgedAgedATP Binding Cassette Transporter, Subfamily G, Member 1MonocytesRisk FactorsATP Binding Cassette Transporter 1Aged, 80 and over

Stichwörter der Autor:innen

CholesterolDiabetesExpression profilingMetabolism

Substanzen

Liver X ReceptorsCholesterolATP Binding Cassette Transporter, Subfamily G, Member 1ATP Binding Cassette Transporter 1

Autor:innen und Institutionen

  • Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
  • Department of Medicine, Division of Cardiology, and.
  • Department of Medicine, Division of Geriatrics, Duke University, Durham, North Carolina, USA.
  • Department of Biological, Geological, and Environmental Sciences, Cleveland State University, Cleveland, Ohio, USA.
  • Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
  • Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, USA.

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • NIA NIH HHS
  • NIDDK NIH HHS
  • NIH

Zitieren

APA

Ding, J., Nguyen, A. T., Lohman, K., Hensley, M. T., Parker, D., Hou, L., Taylor, J., Voora, D., Sawyer, J. K., Boudyguina, E., Bancks, M. P., Bertoni, A., Pankow, J. S., Rotter, J. I., Goodarzi, M. O., Tracy, R. P., Murdoch, D. M., Duprez, A., Rich, S. S., …, & Liu, Y. (2024). LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes. Journal of Clinical Investigation. https://doi.org/10.1172/jci173278

Vancouver

Ding J, Nguyen AT, Lohman K, Hensley MT, Parker D, Hou L, et al. LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes. Journal of Clinical Investigation. 2024. doi:10.1172/jci173278

BibTeX
@article{Ding2024,
  author = {Ding, Jingzhong and Nguyen, Anh Tram and Lohman, Kurt and Hensley, Michael T and Parker, Daniel and Hou, Li and Taylor, Jackson and Voora, Deepak and Sawyer, Janet K and Boudyguina, Elena and Bancks, Michael P and Bertoni, Alain and Pankow, James S and Rotter, Jerome I and Goodarzi, Mark O and Tracy, Russell P and Murdoch, David M and Duprez, Daniel and Rich, Stephen S and Psaty, Bruce M and Siscovick, David and Newgard, Christopher and Herrington, David and Hoeschele, Ina and Shea, Steven and Stein, James H and Patel, Manesh and Post, Wendy and Jacobs, David and Parks, John S and Liu, Yongmei},
  title = {LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci173278}
}
Kostenlos starten →